EGFR and non-small cell lung carcinoma: Active ingredients, such as quercetin, luteolin, kaempferol, and tanshinone IIA can modulate signaling pathways related to NSCLC-EGFR cell resistance, lipids and atherosclerosis, chemical carcinogenesis receptor activation, and neuroactive ligand‒receptor interaction.